Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors

See all

angelo a izzo

University of Naples Federico II

Naples, Italy

Specialty Chief Editor

Gastrointestinal and Hepatic Pharmacology
raquel abalo

Rey Juan Carlos University

Móstoles, Spain

Associate Editor

Gastrointestinal and Hepatic Pharmacology
ludovico abenavoli

Magna Græcia University

Catanzaro, Italy

Associate Editor

Gastrointestinal and Hepatic Pharmacology
hamid i akbarali

Virginia Commonwealth University

Richmond, United States

Associate Editor

Gastrointestinal and Hepatic Pharmacology

Gastrointestinal and Hepatic Pharmacology

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Editors

angelo a izzo

raquel abalo

ludovico abenavoli

hamid i akbarali

Articles

First-Line Treatment of Hepatocellular Carcinoma: A Propensity-Matched Analysis of Tyrosine Kinase Inhibitors Combined with TACE, with or without PD-1 Inhibitors

2-Dodecyl-6-methoxycyclohexa-2, 5-dien-1,4-dione alleviates liver fibrosis and improves intestinal flora and bile acid metabolism

Insights into the Gut-Liver Axis: Mechanisms and Emerging Therapies in Hepatocellular Carcinoma

Effect of propinox and pinaverium bromide on ex vivo colonic motor patterns and their synergistic effect with hyoscine butyl bromide

Research Topics

Pharmacological and Nutritional Approaches to Metabolic Associated Fatty Liver Disease: A Step Towards Achieving SDG 3

Molecular Insights into Fatty Liver Disease: Pathogenesis, Progression, and Therapeutic Strategies

Emerging Talents in Frontiers in Pharmacology: Gastrointestinal and Hepatic Pharmacology 2025

Advances in the Potential Treatments of Gastrointestinal and Liver Diseases: Addressing the Public Health Burden, Volume II